強度変調放射線治療（IMRT）市場- 世界の産業規模、シェア、動向、機会、予測、放射線タイプ別、用途別、エンドユーザー別、地域別、競合別、2019-2029年

世界の強度変調放射線治療（IMRT）市場は2023年に18億2,000万米ドルと評価され、2029年までのCAGRは5.48%で、予測期間中に着実な成長が予測されています。

世界の強度変調放射線治療（IMRT）（IMRT）市場は、ヘルスケア産業においてダイナミックかつ急速に発展している分野であり、がん治療において極めて重要な役割を果たしています。IMRTは最先端の放射線治療技術であり、周囲の健康な組織へのダメージを最小限に抑えながら、がん腫瘍に正確で的を絞った放射線を照射することができます。この高度な治療法は、治療効果を高め、副作用のリスクを低減できることから、ヘルスケア専門家や患者から絶大な人気と支持を得ています。

IMRT市場は、様々な要因によって近年大幅な成長を遂げています。世界のがん罹患率の上昇に加え、がんに対する意識の高まりと早期診断が、先進的で効果的ながん治療の選択肢に対する需要の急増につながっており、IMRTはその顕著な1つです。画像誘導放射線治療（IGRT）や体積変調アーク治療（VMAT）の市場開拓など、放射線治療分野における技術の進歩はIMRT市場をさらに前進させ、より高い精度と個別化された治療計画を可能にしています。

市場はまた、先進地域と新興国市場の両方において、がん治療のインフラと革新的治療へのアクセスを改善するためのヘルスケア投資が増加していることにも影響されています。IMRTの採用は、最先端の治療オプションを提供しようとするヘルスケアプロバイダーや、より低侵襲で的を絞ったがん治療を求める患者によって支えられています。市場では研究開発活動が活発化しており、IMRT技術を強化し、より効率的に、より多くの患者が利用できるようにする努力が続けられています。

主な市場促進要因

がん罹患率の増加

意識の高まりと早期診断

ヘルスケアインフラへの投資

主な市場課題

コストとアクセシビリティ

複雑さと専門性

主な市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の強度変調放射線治療（IMRT）市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 放射線タイプ別（陽子放射線、電子放射線、光子放射線、炭素イオン放射線）
  • 用途別（前立腺がん、肺がん、乳がん、脳腫瘍、婦人科がん、消化器がん、その他のがん）
  • エンドユーザー別（病院・診療所、外来外科、その他）
  • 地域別
  • 企業別（2023）
• 市場マップ
  • 放射線タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋地域の強度変調放射線治療（IMRT）市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 放射線タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の強度変調放射線治療（IMRT）市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 放射線タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の強度変調放射線治療（IMRT）市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 放射線タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の強度変調放射線治療（IMRT）市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 放射線タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの強度変調放射線治療（IMRT）市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 放射線タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の強度変調放射線治療（IMRT）市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Siemens Healthineers AG
• Accuray Incorporated
• Elekta GmbH
• Iba LLC
• Hitachi, Ltd.
• Mevion Medical Systems B.V.
• Koninklijke Philips N.V.
• Raysearch Laboratories AB
• Brainlab AG

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Intensity Modulated Radiotherapy Market was valued at USD 1.82 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.48% through 2029. The Global Intensity-Modulated Radiotherapy (IMRT) Market is a dynamic and rapidly evolving sector within the healthcare industry that plays a pivotal role in the treatment of cancer. IMRT is a cutting-edge radiation therapy technique that allows for precise and targeted delivery of radiation to cancerous tumors while minimizing damage to surrounding healthy tissues. This highly advanced treatment method has gained immense popularity and acceptance among healthcare professionals and patients alike due to its ability to enhance treatment outcomes and reduce the risk of side effects.

The IMRT market has been witnessing substantial growth in recent years, driven by a multitude of factors. The rising global incidence of cancer, coupled with the increasing awareness and early diagnosis, has led to a surge in the demand for advanced and effective cancer treatment options, of which IMRT is a prominent one. Technological advancements in the field of radiation therapy, such as the development of image-guided radiotherapy (IGRT) and volumetric modulated arc therapy (VMAT), have further propelled the IMRT market forward, allowing for even greater precision and personalized treatment plans.

The market is also influenced by increasing healthcare investments, both in developed and developing regions, to improve cancer care infrastructure and access to innovative therapies. The adoption of IMRT is supported by healthcare providers looking to offer state-of-the-art treatment options and by patients seeking less invasive and more targeted cancer therapies. The market has seen a surge in research and development activities, with ongoing efforts to enhance IMRT techniques, making them more efficient and accessible to a wider patient population.

Key Market Drivers

Increasing Incidence of Cancer

The increasing incidence of cancer is a pivotal driver behind the remarkable growth of the Global Intensity Modulated Radiotherapy (IMRT) market. Cancer continues to be a global health crisis, with millions of new cases diagnosed each year. The prevalence of cancer is on the rise due to various factors, including an aging population, lifestyle changes, environmental factors, and improved cancer screening and detection methods. This surge in cancer cases has amplified the demand for advanced and effective cancer treatment modalities, with IMRT standing out as a cutting-edge solution.

IMRT's effectiveness in targeting cancerous tumors with precision and minimizing damage to surrounding healthy tissues has made it a preferred choice in the treatment of cancer. As the incidence of cancer grows, healthcare providers are increasingly turning to IMRT to offer patients a better chance at successful treatment outcomes. The personalized nature of IMRT allows for tailored treatment plans, ensuring that each patient receives the most effective and least invasive therapy possible, leading to improved patient outcomes and a better quality of life during and after treatment.

The early diagnosis plays a significant role in the management of cancer, and the growing awareness of the importance of cancer screening has led to more cases being detected at an earlier, more treatable stage. This has further bolstered the demand for advanced treatments like IMRT, which can be particularly beneficial when used in the early stages of cancer treatment. Early diagnosis combined with the precision and minimal side effects associated with IMRT has made it a crucial component of the comprehensive cancer care strategy.

Growing Awareness and Early Diagnosis

The Global Intensity Modulated Radiotherapy (IMRT) market is experiencing significant growth due to the growing awareness of cancer and the importance of early diagnosis. Cancer awareness campaigns increased public knowledge, and improved screening and diagnostic techniques have all contributed to the early detection of cancer cases. As more individuals are diagnosed earlier, more treatable stages of the disease, the demand for advanced and effective treatment options like IMRT has surged. Early diagnosis is a critical factor in cancer care, as it often leads to more successful treatment outcomes and a higher chance of long-term survival. Patients diagnosed with cancer at an early stage typically have a better prognosis, and IMRT has emerged as a leading treatment choice in such cases. Its precision and ability to target cancerous tumors while sparing healthy tissues make it an ideal option for early-stage cancer patients, ensuring that treatment is as effective as possible.

The reduction in side effects associated with IMRT is particularly advantageous for patients diagnosed early in the course of their disease. Minimizing collateral damage to healthy tissues not only enhances the quality of life during treatment but also improves post-treatment recovery and long-term well-being. Patients are increasingly aware of these benefits, and their preference for less invasive and more targeted therapies has played a significant role in boosting the IMRT market. The global push for cancer awareness, early detection, and prevention has led to increased patient education and proactive healthcare-seeking behavior. As individuals become more informed about the importance of regular check-ups and screenings, healthcare providers have seen a rise in the number of patients diagnosed at early stages. This trend, combined with the advanced technology and personalized approach of IMRT, has significantly contributed to its increasing adoption.

Investment in Healthcare Infrastructure

Investment in healthcare infrastructure is a significant driver behind the growth of the Global Intensity Modulated Radiotherapy (IMRT) market. Across the world, countries and regions are making substantial investments in upgrading their healthcare facilities, including cancer care centers and radiation therapy units. This investment is a direct response to the increasing demand for advanced cancer treatments and the need to provide patients with the best available options, including IMRT. The expansion of healthcare infrastructure involves various components, including the construction of state-of-the-art cancer treatment centers, the acquisition of advanced medical equipment, and the training of healthcare professionals. In particular, radiation therapy facilities are being equipped with the latest IMRT technology, such as linear accelerators, image-guided radiotherapy (IGRT) systems, and volumetric modulated arc therapy (VMAT) capabilities. These technological advancements enable healthcare providers to offer IMRT as a part of their comprehensive cancer care services.

Investments in healthcare infrastructure are driven by a growing awareness of the importance of timely and effective cancer treatment. The incidence of cancer is on the rise, and providing patients with access to the latest and most precise therapies is crucial. IMRT, with its ability to deliver targeted radiation while minimizing damage to surrounding healthy tissues, is an essential component of the evolving cancer care landscape. These investments are aimed at improving access to healthcare services, reducing treatment waiting times, and ensuring that the latest medical technologies are readily available to patients. As healthcare systems evolve to meet these demands, the adoption of IMRT becomes integral in providing patients with the best possible treatment options. The modernization of healthcare infrastructure reflects a commitment to staying at the forefront of medical innovation. Governments and healthcare organizations understand that offering IMRT and other advanced treatments not only enhances patient outcomes but also plays a role in attracting and retaining top-tier medical professionals and researchers.

Key Market Challenges

Cost and Accessibility

The Global Intensity Modulated Radiotherapy (IMRT) market has emerged as a powerful tool in the battle against cancer, offering precise and targeted radiation therapy to improve treatment outcomes while minimizing damage to healthy tissues. However, despite its effectiveness, the market faces significant challenges related to cost and accessibility, which can hinder the widespread adoption of this advanced treatment modality. One of the primary challenges is the high cost associated with IMRT. The equipment required for IMRT, such as linear accelerators and specialized treatment planning software, can be prohibitively expensive. This cost is often passed on to healthcare institutions, which can struggle to finance the acquisition and maintenance of these technologies. As a result, healthcare providers may be hesitant to invest in IMRT, particularly in regions with limited resources.

The complexity of IMRT treatment planning and delivery demands a highly skilled workforce. Radiation oncologists, medical physicists, and radiation therapists must receive specialized training to ensure the accurate and safe administration of IMRT. The shortage of trained professionals in some regions can create a barrier to the accessibility of IMRT, limiting its availability to patients who could benefit from this advanced therapy. Insurance coverage and reimbursement policies are additional factors affecting the accessibility of IMRT. In some cases, insurance companies and government healthcare programs may not fully cover the costs of IMRT, or they may have stringent eligibility criteria. This can lead to financial barriers for patients seeking IMRT, making it less accessible, even when recommended by healthcare providers.

Complexity and Expertise

The Global Intensity Modulated Radiotherapy (IMRT) market has gained recognition as a powerful and precise cancer treatment modality, but it is not without its challenges. One of the key challenges facing the IMRT market is the complexity of the treatment and the expertise required for its successful implementation. This complexity can hinder the widespread adoption of IMRT and limit its accessibility to both healthcare providers and patients. IMRT is a highly sophisticated and intricate radiation therapy technique. It involves the precise delivery of radiation beams to cancerous tumors while minimizing damage to surrounding healthy tissues. The process demands a well-trained and specialized team, including radiation oncologists, medical physicists, and radiation therapists. These professionals must work collaboratively to plan and administer IMRT treatments, ensuring accuracy and patient safety.

The complexity of IMRT treatment planning can be a significant barrier. Healthcare providers need access to advanced treatment planning software and specialized equipment, such as linear accelerators, to create highly individualized treatment plans. These plans must be tailored to the unique characteristics of each patient's cancer, making the process time-consuming and resource intensive. The expertise required to operate and maintain IMRT equipment and ensure the safe delivery of treatment is a critical factor. Radiation oncologists and medical physicists must undergo rigorous training to understand the intricacies of IMRT. Radiation therapists also need specialized training to operate the equipment and monitor patients during treatment. The shortage of skilled professionals, particularly in underserved regions, can limit the adoption of IMRT and hinder its accessibility.

Key Market Trends

Technological Advancements

Technological advancements have emerged as a driving force behind the growth of the Global Intensity Modulated Radiotherapy (IMRT) market. IMRT, a highly precise and targeted radiation therapy modality used in cancer treatment, has benefited significantly from ongoing developments in radiation therapy technology. These advancements have enabled healthcare providers to offer even more effective and patient-specific cancer care, thus propelling the adoption of IMRT. One notable technological trend is the development and integration of image-guided radiotherapy (IGRT). IGRT uses real-time imaging, such as X-rays or CT scans, to monitor and adjust the radiation treatment as it's being delivered. This enhances the precision of IMRT by accounting for any changes in a patient's anatomy or tumor position during the course of treatment. The incorporation of IGRT technology has bolstered the accuracy of IMRT, making it even more effective in targeting cancerous tumors.

Another advancement is the utilization of volumetric modulated arc therapy (VMAT). VMAT is a treatment technique that allows for more efficient and precise delivery of radiation by continuously adjusting the radiation beam's shape and intensity as the treatment machine rotates around the patient. This innovative approach reduces the time required for treatment and enhances the overall patient experience, while maintaining the high level of precision characteristic of IMRT. Adaptive IMRT is yet another technological development that has gained prominence in the field. Adaptive IMRT involves continually adapting the treatment plan based on changes in the patient's anatomy, such as weight loss or tumor regression. This dynamic approach ensures that the radiation therapy remains highly targeted throughout the treatment, increasing its effectiveness in tumor control.

The integration of artificial intelligence (AI) and machine learning into treatment planning and delivery has become a notable trend. These technologies can analyze large datasets and assist healthcare professionals in optimizing IMRT plans, leading to more efficient and personalized treatment approaches. AI and machine learning also play a role in automating quality assurance processes, reducing the potential for human error.

Segmental Insights

Radiation Type Insights

Based on Radiation Type, Proton radiation dominated the Global Intensity Modulated Radiotherapy Market in 2023. Photon radiation sources, such as X-ray machines, are widely available in medical facilities around the world. These machines are relatively cost-effective to operate and maintain, making them accessible to a broader range of healthcare providers. Photons, specifically X-rays, have good tissue penetration characteristics. They can effectively target deep-seated tumors while minimizing damage to surrounding healthy tissues. This is crucial for minimizing side effects and maximizing the therapeutic effect in radiotherapy.

Application Insights

Based on Application, lung cancer emerged as the fastest growing segment in the Global Intensity Modulated Radiotherapy Market during forecast period. This is ascribed due to its high prevalence worldwide and the effectiveness of IMRT in treating complex tumor shapes near critical organs. IMRT's precision allows for targeted radiation delivery, minimizing damage to surrounding healthy tissue. As lung cancer cases continue to rise, particularly due to factors like smoking and environmental pollutants, the demand for advanced treatment options like IMRT grows. The ongoing research and development efforts focus on refining IMRT techniques for lung cancer treatment, further solidifying its dominance in the global market.

Regional Insights

Based on region, North America emerged as the dominant region in the Global Intensity Modulated Radiotherapy Market in 2023, holding the largest market share. Cancer is a major public health concern in North America, with a significant incidence of various cancer types. As a result, there is a substantial demand for advanced cancer treatment options, including IMRT. North America is a hub for medical research and innovation, with a strong emphasis on developing and implementing new medical technologies. This focus on research and development has led to the early adoption and integration of IMRT into cancer treatment protocols. North America typically has more favorable reimbursement policies for medical procedures, including radiation therapy, which can incentivize healthcare providers to offer IMRT to patients.

Key Market Players

Siemens Healthineers AG

Accuray Incorporated

Elekta GmbH

Iba LLC

Hitachi, Ltd.

Mevion Medical Systems B.V.

Koninklijke Philips N.V.

Raysearch Laboratories AB

Brainlab AG

Report Scope:

In this report, the Global Intensity Modulated Radiotherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intensity Modulated Radiotherapy Market, By Radiation Type:

Proton radiation Electron radiation Photon radiation Carbon-lon radiation

Intensity Modulated Radiotherapy Market, By End User:

Hospital & Clinics Ambulatory Surgical care Others

Intensity Modulated Radiotherapy Market, By Application:

Prostate cancer Lung cancer Breast cancer Brain cancer Gynecological cancers Gastrointestinal cancers Other cancers

Intensity Modulated Radiotherapy Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intensity Modulated Radiotherapy Market.

Available Customizations:

Global Intensity Modulated Radiotherapy Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Intensity Modulated Radiotherapy Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Radiation Type (Proton radiation, Electron radiation, Photon radiation, Carbon-lon radiation)
  • 4.2.2. By Application (Prostate cancer, Lung cancer, Breast cancer, Brain cancer, Gynecological cancers, Gastrointestinal cancers, Other cancers)
  • 4.2.3. By End User (Hospital & Clinics, Ambulatory Surgical care, Others)
  • 4.2.4. By Region
  • 4.2.5. By Company (2023)
• 4.3. Market Map
  • 4.3.1. By Radiation Type
  • 4.3.2. By Application
  • 4.3.3. By End User
  • 4.3.4. By Region

5. Asia Pacific Intensity Modulated Radiotherapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Radiation Type
  • 5.2.2. By Application
  • 5.2.3. By End User
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Intensity Modulated Radiotherapy Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Radiation Type
      • 5.3.1.2.2. By Application
      • 5.3.1.2.3. By End User
  • 5.3.2. India Intensity Modulated Radiotherapy Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Radiation Type
      • 5.3.2.2.2. By Application
      • 5.3.2.2.3. By End User
  • 5.3.3. Australia Intensity Modulated Radiotherapy Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Radiation Type
      • 5.3.3.2.2. By Application
      • 5.3.3.2.3. By End User
  • 5.3.4. Japan Intensity Modulated Radiotherapy Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Radiation Type
      • 5.3.4.2.2. By Application
      • 5.3.4.2.3. By End User
  • 5.3.5. South Korea Intensity Modulated Radiotherapy Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Radiation Type
      • 5.3.5.2.2. By Application
      • 5.3.5.2.3. By End User

6. Europe Intensity Modulated Radiotherapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Radiation Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Intensity Modulated Radiotherapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Radiation Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Germany Intensity Modulated Radiotherapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Radiation Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Spain Intensity Modulated Radiotherapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Radiation Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User
  • 6.3.4. Italy Intensity Modulated Radiotherapy Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Radiation Type
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By End User
  • 6.3.5. United Kingdom Intensity Modulated Radiotherapy Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Radiation Type
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By End User

7. North America Intensity Modulated Radiotherapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Radiation Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Intensity Modulated Radiotherapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Radiation Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Mexico Intensity Modulated Radiotherapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Radiation Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Canada Intensity Modulated Radiotherapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Radiation Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User

8. South America Intensity Modulated Radiotherapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Radiation Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Intensity Modulated Radiotherapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Radiation Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Argentina Intensity Modulated Radiotherapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Radiation Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Colombia Intensity Modulated Radiotherapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Radiation Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User

9. Middle East and Africa Intensity Modulated Radiotherapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Radiation Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Intensity Modulated Radiotherapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Radiation Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Saudi Arabia Intensity Modulated Radiotherapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Radiation Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. UAE Intensity Modulated Radiotherapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Radiation Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Intensity Modulated Radiotherapy Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Siemens Healthineers AG
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Accuray Incorporated
• 14.3. Elekta GmbH
• 14.4. Iba LLC
• 14.5. Hitachi, Ltd.
• 14.6. Mevion Medical Systems B.V.
• 14.7. Koninklijke Philips N.V.
• 14.8. Raysearch Laboratories AB
• 14.9. Brainlab AG

15. Strategic Recommendations

16. About Us & Disclaimer